Ensysce Biosciences, Inc.

Leisure Acquisition Corp., trading under the ticker LACQ, is a blank-check company that pursued a business combination with Ensysce Biosciences, Inc., a pharmaceutical technology firm focused on abuse-deterrent and tamper-resistant drug formulations. The SPAC filed an amended Form 8-K/A with the SEC on June 30, 2021, reflecting updated disclosures tied to its de-SPAC transaction. The company IPO'd in 2019 and targeted the healthcare and life sciences sector. Following the completion of its merger, Ensysce Biosciences began trading as a public company on Nasdaq under the ticker ENSC. The transaction represented one of the 2021 wave of SPAC combinations in the pharmaceutical and biotech space. Sign up for SpacDesk to access full filing history, deal timelines, and sponsor data for LACQ and thousands of other SPAC transactions.